It's currently dominated by a few big names in Eli Lilly and Novo Nordisk, but that can change drastically in the future. The ...
Drugmaker Eli Lilly on Wednesday urged a federal appeals court to overturn a $183 million judgment against it in a case ...
ResMed (RMD) stock falls as Wolfe downgrades due to potential label expansion for Eli Lilly's (LLY) tirzepatide in ...
Bridgewater Associates slashed a stake in Apple, halved its Lilly investment, doubled down on Microsoft, and bought Moderna ...
It seems like there's a fresh reason to be even more bullish about the stock every single week. This past week was no exception to the trend. Here's why. Lilly's medicines Zepbound and Mounjaro ...
Consistent in their evaluation, an analyst from JP Morgan keeps a Overweight rating on Eli Lilly with a target price of $1100 ...
Still, it's hard to deny that Eli Lilly's stock keeps getting sweeter as it invests more and more work into understanding the full capabilities of its own medicine. There is no chance that this is ...
Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what its prospects are for the next ...